Given that the plasminogen activation system plays a central role in the regulation of a variety of pathological processes including malignancy, chemoresistance, coagulation, and angiogenesis 21, 22, we further examined whether ADAM9 regulated the plasminogen activation system for the pathogenesis of ESCC cells. This evidence concerns the gene ADAM9 and esophageal squamous cell carcinoma.